AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S

Why did Asia stocks tumble after US tech selloff? How will US steel tariffs affect wind turbine imports? Why is Novo Nordisk freezing hiring globally? What impact will McDonald's price cuts have? How will Trump’s Intel stake affect the chipmaker? Why are Palantir and Nvidia stocks falling? What caused Pop Mart’s revenue to soar?

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S

news.abbvie.com/2025-08-12-AbbVie-Announces-195-Million-Investment-to-Expand-Active-Pharmaceutical-Ingredient-Manufacturing-in-the-U-S

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S. This expansion is part of AbbVie's…

This story appeared on news.abbvie.com, 2025-08-12 20:45:16.075000.